Cargando…
In-vitro antiplatelet effect of melatonin in healthy individuals and patients with type 2 diabetes mellitus
PURPOSE: The incidence of acute myocardial infarctions (AMI) shows circadian variation typically peaking during morning hours with a decline at night. However, this variation does not occur in patients with diabetes mellitus (DM). The night’s decline of AMI may be partially explained by melatonin-re...
Autores principales: | Böhm, A., Lauko, V., Dostalova, K., Balanova, I., Varga, I., Bezak, B., Jajcay, N., Moravcik, R., Lazurova, L., Slezak, P., Mojto, V., Kollarova, M., Petrikova, K., Danova, K., Zeman, M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10632203/ https://www.ncbi.nlm.nih.gov/pubmed/37148530 http://dx.doi.org/10.1007/s40618-023-02102-7 |
Ejemplares similares
-
Association Between Apelin and Atrial Fibrillation in Patients With High Risk of Ischemic Stroke
por: Bohm, Allan, et al.
Publicado: (2021) -
Diquat-induced cytotoxicity on Vero and HeLa cell lines: effect of melatonin and dihydromelatonin
por: Moravčík, Roman, et al.
Publicado: (2014) -
Left Ventricular Hypertrophy and Ventricular Tachyarrhythmia: The Role of Biomarkers
por: Bacharova, Ljuba, et al.
Publicado: (2023) -
Data processing pipeline for cardiogenic shock prediction using machine learning
por: Jajcay, Nikola, et al.
Publicado: (2023) -
Oral antiplatelet therapy in diabetes mellitus and the role of prasugrel: an overview
por: Hillegass, William B, et al.
Publicado: (2011)